PATENT CLAIM ANALYSIS

Application Number: 16173114
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["424", "136100"]

Abstract:
Multispecific proteins that bind and specifically redirect NK cells to lyse a target cell of interest are provided without non-specific activation of NK cells in absence of target cells. The proteins have utility in the treatment of disease, notably cancer or infectious disease.

Claim (Index 82):
The multispecific antigen binding protein of  claim 81 , wherein said infectious agent is a virus, parasite, bacterium or another microbe.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 97.0
- Lexical Diversity: 1.31429
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15190337', '15321650', '14691509', '16041309', '11921123']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8066975233881688
- 35 USC 102 Novelty (BERT): 0.6558926119734394
- Combined Prediction Score: 0.7916170322466959
- Mean Citation Score: 535.968584
- Max Citation Score: 918.7742
- Similarity Product: 589.0310038197279

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test